Memorializing Governor Kathy Hochul to proclaim November 2025, as Pancreatic Cancer Awareness Month in the State of New York
Summary
This resolution memorializes Governor Kathy Hochul to proclaim November 2025 as Pancreatic Cancer Awareness Month in New York State. It is a nonbinding commemorative measure that highlights the severity of pancreatic cancer, citing its high mortality rate, low survival rate, projected increase in cases, and the need for greater public awareness, research, early detection, treatment, and prevention efforts.
The resolution includes background findings about pancreatic cancer’s impact nationally and in New York, noting that it is among the leading causes of cancer death and that thousands of New Yorkers are expected to die from the disease. It also identifies risk factors such as smoking, obesity, recent-onset diabetes, family history, pancreatitis, and higher incidence among certain populations, including people of Eastern European Jewish and African-American descent.
Impact
The bill does not change substantive state law, create a program, or appropriate funds. Its legal effect is limited to urging the Governor to issue a proclamation and encouraging New Yorkers to learn about pancreatic cancer and support research funding, early detection, effective treatments, and prevention programs. The practical impact is symbolic and educational, aimed at public awareness and advocacy rather than regulatory action.
Sentiment
The overall sentiment is strongly supportive and solemn. The resolution frames pancreatic cancer as an urgent public health concern and expresses concern about the disease’s rising incidence, poor survival outcomes, and underfunding of research. Because there are no recorded votes or committee transcripts, there is no evidence of opposition in the available record, and the measure appears to be presented as a consensus awareness resolution.
Contention
No specific points of contention are documented in the available materials. The resolution’s emphasis on research funding, early detection, and prevention suggests the main policy concern is the need for greater attention and resources for a disease with poor outcomes. Any disagreement would likely be limited to the general use of legislative resolutions for awareness campaigns rather than to the substance of pancreatic cancer awareness itself.